The scope maker expects to report $18.6 million in total revenue for the fourth quarter, up from $18.3 million in the fourth quarter of 2014. Revenue for the full year is predicted to be $72.3 million, up 18 percent from $61.4 million in 2014.
The company’s fourth quarter revenue consisted of:
• Imaging: $5.2 million
• Single-use products: $9.5 million
• Pathology: $3.9 million
EndoChoice shipped 25 of its Fuse Endoscopy systems during the fourth quarter of 2015, and a total of 99 were shipped for the full year. The company will report its full fourth quarter and full year financial results March 3.
More articles on gastroenterology:
Dr. Lawrence Kosinski’s SonarMD partners with Digestive Health Center of New Jersey
FDA clears 51 GI/endoscopy devices in 2015
Exact Sciences expects to double number of Cologuard tests completed in 2016
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
